サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1715191

欧州のリキッドバイオプシー用採血管市場：2031年までの予測 - 地域別分析 - 製品別、材料別、用途別、エンドユーザー別

Europe Blood Collection Tubes for Liquid Biopsy Market Forecast to 2031 - Regional Analysis - by Product, Material, Application, and End User

出版日
ページ情報
英文 125 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
欧州のリキッドバイオプシー用採血管市場：2031年までの予測 - 地域別分析 - 製品別、材料別、用途別、エンドユーザー別
出版日: 2025年02月11日
発行: The Insight Partners
ページ情報: 英文 125 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州のリキッドバイオプシー用採血管市場は、2023年に309億4,900万米ドルと評価され、2031年までには1,217億4,227万米ドルに達すると予測され、2023年から2031年までのCAGRは18.7%と推定されます。

他の診断検査手法に対するリキッドバイオプシーの利点が欧州のリキッドバイオプシー用採血管市場を牽引

侵襲的な診断手技は、血腫、出血、組織損傷のリスクを高め、周辺組織に腫瘍細胞を播種します。その結果、診断目的の患者の間では、非侵襲性または低侵襲性の検査に対する選好が高まっています。研究者は、血液サンプルのリキッドバイオプシーによって、固形腫瘍の遺伝的およびエピジェネティックな変化をすべて追跡することができます。リキッドバイオプシーは非侵襲的な診断法であるため、患者のリスクは少ないです。さらに、患者に不快感を与えないため、臨床医はこれらの検査を容易に何度も実施することができます。患者が低侵襲の手技を好むのは、高度な器具の使用によるもので、これにより臨床医や検査室の担当者は、より繊細で複雑な作業を、より少ない痛み、傷跡、リスクで行うことができます。リキッドバイオプシーは最近、がん患者における組織生検に代わる非侵襲的な方法として大きな関心を集めていますが、これは技術の進歩が実現可能性の向上と処理時間の短縮に貢献しているためです。

コンピュータ断層撮影（CT）、磁気共鳴画像法（MRI）、陽電子放射断層撮影（PET）スキャンなどの画像診断技術は高価で時間がかかります。さらに、患者を外部放射線、静脈内造影剤、放射性トレーサーなどにさらします。また、画像検査では、治療によって変化しうる腫瘍の表現型に関する情報は得られません。組織生検技術は腫瘍の表現型に関する情報を提供することができますが、コストの制限や患者へのリスクを考慮すると、連続組織生検を実施することは現実的ではありません。それに対してリキッドバイオプシーは、比較的低コストで、実質的に継続的にがんの負担と表現型の情報を評価することができます。リキッドバイオプシーは、様々な生理学的あるいは病態生理学的プロセスを評価する非侵襲的あるいは低侵襲的な手段を提供し、それによって組織生検や他の侵襲的処置に取って代わります。この場合、リキッドバイオプシーは、血液サンプルから循環腫瘍細胞や循環遊離核酸を分析することにより、内視鏡検査、針生検、手術の必要性を回避することができます。

欧州のリキッドバイオプシー用採血管市場概要

2022年6月にJournal of Thoracic Oncologyに掲載された「Lung Cancer in Germany」論文によると、がんはドイツで2番目に多い死因の一つであり、全死亡の25%を占めています。年齢標準化罹患率は男性で52.1％、女性で32.7％（10万人当たり）です。がんと診断される平均年齢は男性で70歳、女性で69歳で、全体の52％がステージIVです。がんの有病率の増加は、ドイツにおけるリキッドバイオプシー用採血管市場の成長を促進しています。さらにBARMERは、大腸がん患者に実施されるOncoBEAM RAS CRC IVD Testをカバーしています。この革新的なリキッドバイオプシー診断法は、採血管1本分という少ない血液量でRAS変異の包括的な評価を提供します。この償還オプションは、腫瘍治療の近代化における重要なマイルストーンであり、患者が最も適切な治療法をタイムリーに選択するための重要な情報を入手できるようにするものです。

欧州のリキッドバイオプシー用採血管市場収益と2031年までの予測（金額）

欧州のリキッドバイオプシー用採血管市場セグメンテーション

欧州のリキッドバイオプシー用採血管市場は、製品、材料、用途、エンドユーザー、国に分類されます。

製品別では、欧州のリキッドバイオプシー用採血管市場は、ccfDNA/cfDNAチューブ、cfRNAチューブ、CTCチューブ、gDNAチューブ、細胞内RNAチューブ、その他に区分されます。ccfDNA/cfDNA Tubesセグメントは、2023年の欧州のリキッドバイオプシー用採血管市場シェアで最大のシェアを占めました。

材料別では、欧州のリキッドバイオプシー用採血管市場はプラスチックとガラスに区分されます。2023年の欧州のリキッドバイオプシー用採血管市場シェアでは、プラスチックセグメントが大きなシェアを占めました。

用途別では、欧州のリキッドバイオプシー用採血管市場は体外診断（IVD）と調査に二分されます。2023年の欧州のリキッドバイオプシー用採血管市場シェアでは、体外診断（IVD）分野が大きなシェアを占めました。

エンドユーザー別では、欧州のリキッドバイオプシー用採血管市場は遺伝子診断ラボ、研究開発センター、従来型診断センター、その他に区分されます。遺伝子診断ラボセグメントが2023年の欧州のリキッドバイオプシー用採血管市場シェアで最大のシェアを占めました。

国別では、欧州のリキッドバイオプシー用採血管市場は、英国、ドイツ、フランス、イタリア、スペイン、その他欧州に区分されます。ドイツセグメントが2023年の欧州のリキッドバイオプシー用採血管市場で最大のシェアを占めました。

Biocept Inc、Exact Sciences Corp、F. Hoffmann-La Roche Ltd、Greiner Bio-One International GmbH、MagBio Genomics, Inc、Norgen Biotek Corp、QIAGEN NV、Streck Inc、and Zymo Research Corporationは、欧州のリキッドバイオプシー用採血管市場で事業を展開する主要企業の一部です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 2次調査
  • 1次調査
    • 仮説の策定
    • マクロ経済要因分析
    • ファンデーション数値の開発
    • データの三角測量
    • 国レベルのデータ

第4章 欧州のリキッドバイオプシー用採血管市場-主要市場力学

  • 欧州のリキッドバイオプシー用採血管市場：主要市場力学
  • 市場促進要因
    • がんの有病率の増加
    • 他の診断検査技術に対するリキッドバイオプシーの優位性
  • 市場抑制要因
    • 熟練した専門家の不足
  • 市場機会
    • がんモニタリングにおけるリキッドバイオプシーの利用
  • 今後の動向
    • リキッドバイオプシーにおける技術の進歩
  • 促進要因と抑制要因の影響

第5章 リキッドバイオプシー用採血管市場：欧州分析

  • 欧州のリキッドバイオプシー用採血管市場収益、2021年～2031年
  • 欧州のリキッドバイオプシー用採血管市場予測分析

第6章 欧州のリキッドバイオプシー用採血管市場分析：製品別

  • ccfDNA/cfDNAチューブ
  • cfRNAチューブ
  • CTCチューブ
  • gDNAチューブ
  • 細胞内RNAチューブ
  • その他

第7章 欧州のリキッドバイオプシー用採血管市場分析：材料別

  • プラスチック
  • ガラス

第8章 欧州のリキッドバイオプシー用採血管の市場分析：用途別

  • 体外診断薬（IVD）
  • 研究

第9章 欧州のリキッドバイオプシー用採血管市場分析：エンドユーザー別

  • 遺伝子診断ラボ
  • 研究開発センター
  • 従来の診断センター
  • その他

第10章 欧州のリキッドバイオプシー用採血管市場：国別分析

    • 欧州
      • 英国
      • ドイツ
      • フランス
      • イタリア
      • スペイン
      • その他欧州

第11章 リキッドバイオプシー用採血管市場：業界情勢

  • リキッドバイオプシー用採血管市場の成長戦略
  • 有機的成長戦略
  • 無機的成長戦略

第12章 企業プロファイル

  • Biocept Inc
  • F. Hoffmann-La Roche Ltd
  • Streck Inc
  • MagBio Genomics, Inc
  • Zymo Research Corporation
  • Norgen Biotek Corp
  • Exact Sciences Corp
  • QIAGEN NV
  • Greiner Bio-One International GmbH

第13章 付録

図表

List Of Tables

  • Table 1. Europe Blood Collection Tubes for Liquid Biopsy Market Segmentation
  • Table 2. Europe Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Table 3. Europe Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by Product
  • Table 4. Europe Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by Material
  • Table 5. Europe Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by Application
  • Table 6. Europe Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by End User
  • Table 1. United Kingdom: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by Product
  • Table 2. United Kingdom: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by Material
  • Table 3. United Kingdom: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by Application
  • Table 4. United Kingdom: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by End User
  • Table 5. Germany: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by Product
  • Table 6. Germany: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by Material
  • Table 7. Germany: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by Application
  • Table 8. Germany: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by End User
  • Table 9. France: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by Product
  • Table 10. France: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by Material
  • Table 11. France: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by Application
  • Table 12. France: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by End User
  • Table 13. Italy: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by Product
  • Table 14. Italy: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by Material
  • Table 15. Italy: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by Application
  • Table 16. Italy: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by End User
  • Table 17. Spain: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by Product
  • Table 18. Spain: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by Material
  • Table 19. Spain: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by Application
  • Table 20. Spain: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by End User
  • Table 21. Rest of Europe: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by Product
  • Table 22. Rest of Europe: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by Material
  • Table 23. Rest of Europe: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by Application
  • Table 24. Rest of Europe: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by End User
  • Table 25. Recent Organic Growth Strategies in Blood Collection Tubes for Liquid Biopsy Market
  • Table 26. Recent Inorganic Growth Strategies in the Blood Collection Tubes for Liquid Biopsy Market

List Of Figures

  • Figure 1. Europe Blood Collection Tubes for Liquid Biopsy Market Segmentation, by Country
  • Figure 2. Impact Analysis of Drivers and Restraints
  • Figure 3. Europe Blood Collection Tubes for Liquid Biopsy Market Revenue (US$ Thousand), 2021-2031
  • Figure 4. Europe Blood Collection Tubes for Liquid Biopsy Market Share (%) - by Product (2023 and 2031)
  • Figure 5. ccfDNA/cfDNA Tubes: Europe Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 6. cfRNA Tubes: Europe Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 7. CTC Tubes: Europe Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 8. gDNA Tubes: Europe Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 9. Intracellular RNA Tubes: Europe Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 10. Others: Europe Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 11. Europe Blood Collection Tubes for Liquid Biopsy Market Share (%) - by Material (2023 and 2031)
  • Figure 12. Plastic: Europe Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 13. Glass: Europe Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 14. Europe Blood Collection Tubes for Liquid Biopsy Market Share (%) - by Application (2023 and 2031)
  • Figure 15. In-vitro Diagnostics (IVD): Europe Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 16. Research: Europe Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 17. Europe Blood Collection Tubes for Liquid Biopsy Market Share (%) - by End User (2023 and 2031)
  • Figure 18. Genetic Diagnostic Labs: Europe Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 19. Research and Development Centres: Europe Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 20. Conventional Diagnostic Centres: Europe Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 21. Others: Europe Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 22. Europe Blood Collection Tubes for Liquid Biopsy Market by Key Countries - Revenue (2023) US$ Million
  • Figure 23. Europe: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 24. United Kingdom: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 25. Germany: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 26. France: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 27. Italy: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 28. Spain: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 29. Rest of Europe: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 30. Growth Strategies in Blood Collection Tubes for Liquid Biopsy Market
目次
Product Code: TIPRE00027974

The Europe blood collection tubes for liquid biopsy market was valued at US$ 30,949.00 million in 2023 and is expected to reach US$ 1,21,742.27 million by 2031; it is estimated to register a CAGR of 18.7% from 2023 to 2031.

Advantages of Liquid Biopsy Over Other Diagnostic Testing Techniques Drive Europe Blood Collection Tubes for Liquid Biopsy Market

Invasive diagnostic procedures increase the risk of hematoma, hemorrhage, and tissue damage, seeding tumor cells in surrounding tissues. As a result, there is a growing preference for noninvasive or minimally invasive tests among patients for diagnostic purposes. Researchers can trace all genetic and epigenetic changes in solid tumors through the liquid biopsy of blood samples. Patients are at lesser risk with liquid biopsies, since it is a noninvasive technique of diagnosis. Moreover, clinicians can readily conduct these tests multiple times, as the procedures don't subject patients to much discomfort. Patients prefer minimally invasive procedures due to the use of advanced instruments, which allow clinicians or laboratory personnel to perform more delicate and complex work with less pain, scarring, and risk. Liquid biopsy has recently gathered considerable interest as a noninvasive alternative to tissue biopsy in cancer patients, owing to technological advancements contributing to improved feasibility and reduced processing times.

Computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET) scan, among other imaging techniques, are expensive and time-consuming. Moreover, they expose patients to external radiation, intravenous contrast, and radioactive tracers, among others. Imaging studies also fail to provide any information about the phenotype of the tumor, which can change with the treatment given. Although tissue biopsy techniques can offer information on tumor phenotype information, it is not feasible to perform serial tissue biopsies, considering cost limitations and risks to patients. Liquid biopsy, on the contrary, could provide a virtually continuous assessment of cancer burden and phenotype information at a relatively low cost. Liquid biopsy offers noninvasive or minimally invasive means of assessing various physiological or pathophysiological processes, thereby replacing tissue biopsy or other invasive procedures. Liquid biopsy, in this case, could circumvent the need for endoscopy, needle biopsy, or surgery by analyzing a blood sample for circulating tumor cells or circulating free nucleic acids.

Europe Blood Collection Tubes for Liquid Biopsy Market Overview

According to the "Lung Cancer in Germany" article, published in the Journal of Thoracic Oncology in June 2022, cancer is among the second most frequent cause of death in Germany, accounting for 25% of all deaths. With an age-standardized incidence rate of 52.1% and 32.7% (per 100,000) in men and women, respectively. The average age at which individuals are diagnosed with cancer is 70 years in men and 69 years in women, and 52% of the total patients are at stage IV. The increasing prevalence of cancer thus fuels the growth of the blood collection tubes for liquid biopsy market in Germany. Moreover, BARMER covers the OncoBEAM RAS CRC IVD Test performed in colorectal cancer patients. This innovative liquid biopsy diagnostic method delivers a comprehensive evaluation of RAS mutations using blood volume as low as a single tube. This reimbursement option marks an important milestone in the modernization of oncology care, granting patients access to critical information for the timely selection of the most appropriate therapy.

Europe Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecast to 2031 (US$ Million)

Europe Blood Collection Tubes for Liquid Biopsy Market Segmentation

The Europe blood collection tubes for liquid biopsy market is categorized into product, material, application, end user, country.

By product, the Europe blood collection tubes for liquid biopsy market is segmented into ccfDNA/cfDNA Tubes, cfRNA Tubes, CTC Tubes, gDNA Tubes, intracellular RNA Tubes, and others. The ccfDNA/cfDNA Tubes segment held the largest share of the Europe blood collection tubes for liquid biopsy market share in 2023.

In terms of material, the Europe blood collection tubes for liquid biopsy market is segmented into plastic and glass. The plastic segment held a larger share of the Europe blood collection tubes for liquid biopsy market share in 2023.

By application, the Europe blood collection tubes for liquid biopsy market is bifurcated into in-vitro diagnostics (IVD) and research. The in-vitro diagnostics (IVD) segment held a larger share of the Europe blood collection tubes for liquid biopsy market share in 2023.

In terms of end user, the Europe blood collection tubes for liquid biopsy market is segmented into genetic diagnostic labs, research and development centers, conventional diagnostic centers, and others. The genetic diagnostic labs segment held the largest share of the Europe blood collection tubes for liquid biopsy market share in 2023.

Based on country, the Europe blood collection tubes for liquid biopsy market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany segment held the largest share of Europe blood collection tubes for liquid biopsy market in 2023.

Biocept Inc; Exact Sciences Corp; F. Hoffmann-La Roche Ltd; Greiner Bio-One International GmbH; MagBio Genomics, Inc; Norgen Biotek Corp; QIAGEN NV; Streck Inc; and Zymo Research Corporation are some of the leading companies operating in the Europe blood collection tubes for liquid biopsy market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Europe Blood Collection Tubes for Liquid Biopsy Market - Key Market Dynamics

  • 4.1 Europe Blood Collection Tubes for Liquid Biopsy Market - Key Market Dynamics
  • 4.2 Market Drivers:
    • 4.2.1 Increase in Prevalence of Cancer
    • 4.2.2 Advantages of Liquid Biopsy Over Other Diagnostic Testing Techniques
  • 4.3 Market Restraints
    • 4.3.1 Lack of Skilled Professionals
  • 4.4 Market Opportunities
    • 4.4.1 Use of Liquid Biopsy in Cancer Monitoring
  • 4.5 Future Trends
    • 4.5.1 Technological Advancements in Liquid Biopsy
  • 4.6 Impact of Drivers and Restraints:

5. Blood Collection Tubes for Liquid Biopsy Market - Europe Analysis

  • 5.1 Europe Blood Collection Tubes for Liquid Biopsy Market Revenue (US$ Thousand), 2021-2031
  • 5.2 Europe Blood Collection Tubes for Liquid Biopsy Market Forecast Analysis

6. Europe Blood Collection Tubes for Liquid Biopsy Market Analysis - by Product

  • 6.1 ccfDNA/cfDNA Tubes
    • 6.1.1 Overview
    • 6.1.2 ccfDNA/cfDNA Tubes: Europe Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 6.2 cfRNA Tubes
    • 6.2.1 Overview
    • 6.2.2 cfRNA Tubes: Europe Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 6.3 CTC Tubes
    • 6.3.1 Overview
    • 6.3.2 CTC Tubes: Europe Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 6.4 gDNA Tubes
    • 6.4.1 Overview
    • 6.4.2 gDNA Tubes: Europe Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 6.5 Intracellular RNA Tubes
    • 6.5.1 Overview
    • 6.5.2 Intracellular RNA Tubes: Europe Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 6.6 Others
    • 6.6.1 Overview
    • 6.6.2 Others: Europe Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)

7. Europe Blood Collection Tubes for Liquid Biopsy Market Analysis - by Material

  • 7.1 Plastic
    • 7.1.1 Overview
    • 7.1.2 Plastic: Europe Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 7.2 Glass
    • 7.2.1 Overview
    • 7.2.2 Glass: Europe Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)

8. Europe Blood Collection Tubes for Liquid Biopsy Market Analysis - by Application

  • 8.1 In-vitro Diagnostics (IVD)
    • 8.1.1 Overview
    • 8.1.2 In-vitro Diagnostics (IVD): Europe Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 8.2 Research
    • 8.2.1 Overview
    • 8.2.2 Research: Europe Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)

9. Europe Blood Collection Tubes for Liquid Biopsy Market Analysis - by End User

  • 9.1 Genetic Diagnostic Labs
    • 9.1.1 Overview
    • 9.1.2 Genetic Diagnostic Labs: Europe Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 9.2 Research and Development Centres
    • 9.2.1 Overview
    • 9.2.2 Research and Development Centres: Europe Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 9.3 Conventional Diagnostic Centres
    • 9.3.1 Overview
    • 9.3.2 Conventional Diagnostic Centres: Europe Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 9.4 Others
    • 9.4.1 Overview
    • 9.4.2 Others: Europe Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)

10. Europe Blood Collection Tubes for Liquid Biopsy Market - Country Analysis

  • 10.1 Europe Blood Collection Tubes for Liquid Biopsy Market, by Key Countries - Revenue (2023) US$ Million
    • 10.1.1 Europe: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast Analysis - by Country
      • 10.1.1.1 United Kingdom: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 10.1.1.1.1 United Kingdom: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Product
        • 10.1.1.1.2 United Kingdom: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Material
        • 10.1.1.1.3 United Kingdom: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Application
        • 10.1.1.1.4 United Kingdom: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by End User
      • 10.1.1.2 Germany: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 10.1.1.2.1 Germany: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Product
        • 10.1.1.2.2 Germany: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Material
        • 10.1.1.2.3 Germany: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Application
        • 10.1.1.2.4 Germany: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by End User
      • 10.1.1.3 France: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 10.1.1.3.1 France: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Product
        • 10.1.1.3.2 France: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Material
        • 10.1.1.3.3 France: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Application
        • 10.1.1.3.4 France: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by End User
      • 10.1.1.4 Italy: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 10.1.1.4.1 Italy: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Product
        • 10.1.1.4.2 Italy: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Material
        • 10.1.1.4.3 Italy: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Application
        • 10.1.1.4.4 Italy: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by End User
      • 10.1.1.5 Spain: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 10.1.1.5.1 Spain: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Product
        • 10.1.1.5.2 Spain: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Material
        • 10.1.1.5.3 Spain: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Application
        • 10.1.1.5.4 Spain: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by End User
      • 10.1.1.6 Rest of Europe: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 10.1.1.6.1 Rest of Europe: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Product
        • 10.1.1.6.2 Rest of Europe: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Material
        • 10.1.1.6.3 Rest of Europe: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Application
        • 10.1.1.6.4 Rest of Europe: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by End User

11. Blood Collection Tubes for Liquid Biopsy Market - Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Blood Collection Tubes for Liquid Biopsy Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Biocept Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 F. Hoffmann-La Roche Ltd
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Streck Inc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 MagBio Genomics, Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Zymo Research Corporation
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Norgen Biotek Corp
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Exact Sciences Corp
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 QIAGEN NV
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Greiner Bio-One International GmbH
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners